The Current Ratio as of December 2024 (TTM) for Coeptis Therapeutics, Inc. (COEP) is 0.40

According to Coeptis Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.40. This represents a change of -63.11% compared to the average of 1.08 of the last 4 quarters.

Coeptis Therapeutics, Inc. (COEP) Historical Current Ratio (quarterly & annually)

How has COEP Current Ratio performed in the past?

The mean historical Current Ratio of Coeptis Therapeutics, Inc. over the last ten years is 0.62. The current 0.40 Current Ratio has changed 6.28% with respect to the historical average. Over the past ten years (40 quarters), COEP's Current Ratio was at its highest in in the March 2021 quarter at 26.54. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Coeptis Therapeutics, Inc. (COEP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Coeptis Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coeptis Therapeutics, Inc. (COEP) Average Current Ratio

How has COEP Current Ratio performed in the past?

The current Current Ratio of Coeptis Therapeutics, Inc. (COEP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Coeptis Therapeutics, Inc. (COEP) Current Ratio vs. Peers

How is COEP’s Current Ratio compared to its peers?

Coeptis Therapeutics, Inc.’s Current Ratio is less than SeaStar Medical Holding Corporation (0.54), less than Virios Therapeutics, Inc. (7.27), less than ZyVersa Therapeutics, Inc. (33.83), less than Sonnet BioTherapeutics Holdings, Inc. (0.66), less than Revelation Biosciences, Inc. (1.64), less than Clearmind Medicine Inc. (1.71), less than Hillstream BioPharma, Inc. (2.25), less than Magenta Therapeutics, Inc. (14.64), less than Quoin Pharmaceuticals, Ltd. (3.02), less than Genelux Corporation (6.47), less than Comera Life Sciences Holdings, Inc. (0.90), less than Dyadic International, Inc. (5.15), less than Cingulate Inc. (7.35), less than Monopar Therapeutics Inc. (5.41), less than YS Biopharma Co., Ltd. (0.94), less than Allarity Therapeutics, Inc. (2.75), greater than Kiromic BioPharma, Inc. (0.22), greater than Aditxt, Inc. (0.09), less than Palisade Bio, Inc. (3.31), less than Plus Therapeutics, Inc. (0.44),

Build a custom stock screener for Coeptis Therapeutics, Inc. (COEP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coeptis Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coeptis Therapeutics, Inc. (COEP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coeptis Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.